▶ 調査レポート

心臓バイオマーカーの世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Cardiac Biomarker Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。心臓バイオマーカーの世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Cardiac Biomarker Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-03560資料のイメージです。• レポートコード:D005-03560
• 出版社/出版日:GlobalInfoResearch / 2020年5月22日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、心臓バイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。心臓バイオマーカーの種類別市場規模(クレアチンキナーゼ(CK)MB、トロポニン(cTnIおよびcTnT)、BNPおよびNT-proBNP、ミオグロブリン、その他(hs-CRP、D-Dimerなど))、用途別市場規模(心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Abbott、Siemens Healthcare、Biomerieux、Roche Diagnostics、Response Biomedical、BG Medicine、Thermo Scientific、DiaDexus、Critical Diagnostics、Singulex
・地域別グローバル市場分析 2015年-2020年
・心臓バイオマーカーの北米市場(アメリカ、カナダ、メキシコ)
・心臓バイオマーカーのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・心臓バイオマーカーのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・心臓バイオマーカーの南米市場(ブラジル、アルゼンチン)
・心臓バイオマーカーの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:クレアチンキナーゼ(CK)MB、トロポニン(cTnIおよびcTnT)、BNPおよびNT-proBNP、ミオグロブリン、その他(hs-CRP、D-Dimerなど)
・用途別分析:心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Cardiac Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Cardiac Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Cardiac Biomarker market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Cardiac Biomarker market has been segmented into
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others (hs-CRP, D-Dimer, etc.)

By Application, Cardiac Biomarker has been segmented into:
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cardiac Biomarker market presented in the report. This section sheds light on the sales growth of different regional and country-level Cardiac Biomarker markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cardiac Biomarker market.

The report offers in-depth assessment of the growth and other aspects of the Cardiac Biomarker market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Cardiac Biomarker Market Share Analysis
Cardiac Biomarker competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cardiac Biomarker sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cardiac Biomarker sales, revenue and market share for each player covered in this report.

The major players covered in Cardiac Biomarker are:
Abbott
Siemens Healthcare
Biomerieux
Roche Diagnostics
Response Biomedical
BG Medicine
Thermo Scientific
DiaDexus
Critical Diagnostics
Singulex

Among other players domestic and global, Cardiac Biomarker market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiac Biomarker product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cardiac Biomarker, with price, sales, revenue and global market share of Cardiac Biomarker in 2018 and 2019.
Chapter 3, the Cardiac Biomarker competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiac Biomarker breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cardiac Biomarker market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cardiac Biomarker sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Cardiac Biomarker Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cardiac Biomarker Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Creatine kinase (CK) MB
1.2.3 Troponin (cTnI and cTnT)
1.2.4 BNP & NT-proBNP
1.2.5 Myogloblin
1.2.6 Others (hs-CRP, D-Dimer, etc.)
1.3 Market Analysis by Application
1.3.1 Overview: Global Cardiac Biomarker Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Overview of Global Cardiac Biomarker Market
1.4.1 Global Cardiac Biomarker Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Siemens Healthcare
2.2.1 Siemens Healthcare Details
2.2.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Siemens Healthcare SWOT Analysis
2.2.4 Siemens Healthcare Product and Services
2.2.5 Siemens Healthcare Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biomerieux
2.3.1 Biomerieux Details
2.3.2 Biomerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biomerieux SWOT Analysis
2.3.4 Biomerieux Product and Services
2.3.5 Biomerieux Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche Diagnostics
2.4.1 Roche Diagnostics Details
2.4.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche Diagnostics SWOT Analysis
2.4.4 Roche Diagnostics Product and Services
2.4.5 Roche Diagnostics Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Response Biomedical
2.5.1 Response Biomedical Details
2.5.2 Response Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Response Biomedical SWOT Analysis
2.5.4 Response Biomedical Product and Services
2.5.5 Response Biomedical Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 BG Medicine
2.6.1 BG Medicine Details
2.6.2 BG Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BG Medicine SWOT Analysis
2.6.4 BG Medicine Product and Services
2.6.5 BG Medicine Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Thermo Scientific
2.7.1 Thermo Scientific Details
2.7.2 Thermo Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Thermo Scientific SWOT Analysis
2.7.4 Thermo Scientific Product and Services
2.7.5 Thermo Scientific Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 DiaDexus
2.8.1 DiaDexus Details
2.8.2 DiaDexus Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 DiaDexus SWOT Analysis
2.8.4 DiaDexus Product and Services
2.8.5 DiaDexus Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Critical Diagnostics
2.9.1 Critical Diagnostics Details
2.9.2 Critical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Critical Diagnostics SWOT Analysis
2.9.4 Critical Diagnostics Product and Services
2.9.5 Critical Diagnostics Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Singulex
2.10.1 Singulex Details
2.10.2 Singulex Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Singulex SWOT Analysis
2.10.4 Singulex Product and Services
2.10.5 Singulex Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cardiac Biomarker Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cardiac Biomarker Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cardiac Biomarker Manufacturer Market Share in 2019
3.3.2 Top 6 Cardiac Biomarker Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cardiac Biomarker Sales, Revenue and Market Share by Regions
4.1.1 Global Cardiac Biomarker Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cardiac Biomarker Revenue and Market Share by Regions (2015-2020)
4.2 North America Cardiac Biomarker Sales and Growth Rate (2015-2020)
4.3 Europe Cardiac Biomarker Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cardiac Biomarker Sales and Growth Rate (2015-2020)
4.5 South America Cardiac Biomarker Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cardiac Biomarker Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cardiac Biomarker Sales, Revenue and Market Share by Country
5.1.1 North America Cardiac Biomarker Sales and Market Share by Country (2015-2020)
5.1.2 North America Cardiac Biomarker Revenue and Market Share by Country (2015-2020)
5.2 United States Cardiac Biomarker Sales and Growth Rate (2015-2020)
5.3 Canada Cardiac Biomarker Sales and Growth Rate (2015-2020)
5.4 Mexico Cardiac Biomarker Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cardiac Biomarker Sales, Revenue and Market Share by Country
6.1.1 Europe Cardiac Biomarker Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cardiac Biomarker Revenue and Market Share by Country (2015-2020)
6.2 Germany Cardiac Biomarker Sales and Growth Rate (2015-2020)
6.3 UK Cardiac Biomarker Sales and Growth Rate (2015-2020)
6.4 France Cardiac Biomarker Sales and Growth Rate (2015-2020)
6.5 Russia Cardiac Biomarker Sales and Growth Rate (2015-2020)
6.6 Italy Cardiac Biomarker Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cardiac Biomarker Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cardiac Biomarker Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cardiac Biomarker Revenue and Market Share by Regions (2015-2020)
7.2 China Cardiac Biomarker Sales and Growth Rate (2015-2020)
7.3 Japan Cardiac Biomarker Sales and Growth Rate (2015-2020)
7.4 Korea Cardiac Biomarker Sales and Growth Rate (2015-2020)
7.5 India Cardiac Biomarker Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cardiac Biomarker Sales and Growth Rate (2015-2020)
7.7 Australia Cardiac Biomarker Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cardiac Biomarker Sales, Revenue and Market Share by Country
8.1.1 South America Cardiac Biomarker Sales and Market Share by Country (2015-2020)
8.1.2 South America Cardiac Biomarker Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cardiac Biomarker Sales and Growth Rate (2015-2020)
8.3 Argentina Cardiac Biomarker Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cardiac Biomarker Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cardiac Biomarker Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cardiac Biomarker Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cardiac Biomarker Sales and Growth Rate (2015-2020)
9.3 Turkey Cardiac Biomarker Sales and Growth Rate (2015-2020)
9.4 Egypt Cardiac Biomarker Sales and Growth Rate (2015-2020)
9.5 South Africa Cardiac Biomarker Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cardiac Biomarker Sales and Market Share by Type (2015-2020)
10.2 Global Cardiac Biomarker Revenue and Market Share by Type (2015-2020)
10.3 Global Cardiac Biomarker Price by Type (2015-2020)
11 Global Cardiac Biomarker Market Segment by Application
11.1 Global Cardiac Biomarker Sales Market Share by Application (2015-2020)
11.2 Global Cardiac Biomarker Revenue Market Share by Application (2015-2020)
11.3 Global Cardiac Biomarker Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cardiac Biomarker Sales, Revenue and Growth Rate (2021-2025)
12.2 Cardiac Biomarker Market Forecast by Regions (2021-2025)
12.2.1 North America Cardiac Biomarker Market Forecast (2021-2025)
12.2.2 Europe Cardiac Biomarker Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cardiac Biomarker Market Forecast (2021-2025)
12.2.4 South America Cardiac Biomarker Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cardiac Biomarker Market Forecast (2021-2025)
12.3 Cardiac Biomarker Market Forecast by Type (2021-2025)
12.3.1 Global Cardiac Biomarker Sales Forecast by Type (2021-2025)
12.3.2 Global Cardiac Biomarker Market Share Forecast by Type (2021-2025)
12.4 Cardiac Biomarker Market Forecast by Application (2021-2025)
12.4.1 Global Cardiac Biomarker Sales Forecast by Application (2021-2025)
12.4.2 Global Cardiac Biomarker Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Cardiac Biomarker Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cardiac Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cardiac Biomarker Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbott Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Cardiac Biomarker Major Business
Table 9. Abbott Cardiac Biomarker Total Revenue (USD Million) (2018-2019)
Table 10. Abbott SWOT Analysis
Table 11. Abbott Cardiac Biomarker Product and Services
Table 12. Abbott Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 14. Siemens Healthcare Cardiac Biomarker Major Business
Table 15. Siemens Healthcare Cardiac Biomarker Total Revenue (USD Million) (2018-2019)
Table 16. Siemens Healthcare SWOT Analysis
Table 17. Siemens Healthcare Cardiac Biomarker Product and Services
Table 18. Siemens Healthcare Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Biomerieux Basic Information, Manufacturing Base and Competitors
Table 20. Biomerieux Cardiac Biomarker Major Business
Table 21. Biomerieux Cardiac Biomarker Total Revenue (USD Million) (2018-2019)
Table 22. Biomerieux SWOT Analysis
Table 23. Biomerieux Cardiac Biomarker Product and Services
Table 24. Biomerieux Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 26. Roche Diagnostics Cardiac Biomarker Major Business
Table 27. Roche Diagnostics Cardiac Biomarker Total Revenue (USD Million) (2018-2019)
Table 28. Roche Diagnostics SWOT Analysis
Table 29. Roche Diagnostics Cardiac Biomarker Product and Services
Table 30. Roche Diagnostics Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Response Biomedical Basic Information, Manufacturing Base and Competitors
Table 32. Response Biomedical Cardiac Biomarker Major Business
Table 33. Response Biomedical Cardiac Biomarker Total Revenue (USD Million) (2018-2019)
Table 34. Response Biomedical SWOT Analysis
Table 35. Response Biomedical Cardiac Biomarker Product and Services
Table 36. Response Biomedical Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. BG Medicine Basic Information, Manufacturing Base and Competitors
Table 38. BG Medicine Cardiac Biomarker Major Business
Table 39. BG Medicine Cardiac Biomarker Total Revenue (USD Million) (2018-2019)
Table 40. BG Medicine SWOT Analysis
Table 41. BG Medicine Cardiac Biomarker Product and Services
Table 42. BG Medicine Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Thermo Scientific Basic Information, Manufacturing Base and Competitors
Table 44. Thermo Scientific Cardiac Biomarker Major Business
Table 45. Thermo Scientific Cardiac Biomarker Total Revenue (USD Million) (2018-2019)
Table 46. Thermo Scientific SWOT Analysis
Table 47. Thermo Scientific Cardiac Biomarker Product and Services
Table 48. Thermo Scientific Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. DiaDexus Basic Information, Manufacturing Base and Competitors
Table 50. DiaDexus Cardiac Biomarker Major Business
Table 51. DiaDexus Cardiac Biomarker Total Revenue (USD Million) (2018-2019)
Table 52. DiaDexus SWOT Analysis
Table 53. DiaDexus Cardiac Biomarker Product and Services
Table 54. DiaDexus Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Critical Diagnostics Basic Information, Manufacturing Base and Competitors
Table 56. Critical Diagnostics Cardiac Biomarker Major Business
Table 57. Critical Diagnostics Cardiac Biomarker Total Revenue (USD Million) (2018-2019)
Table 58. Critical Diagnostics SWOT Analysis
Table 59. Critical Diagnostics Cardiac Biomarker Product and Services
Table 60. Critical Diagnostics Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Singulex Basic Information, Manufacturing Base and Competitors
Table 62. Singulex Cardiac Biomarker Major Business
Table 63. Singulex Cardiac Biomarker Total Revenue (USD Million) (2018-2019)
Table 64. Singulex SWOT Analysis
Table 65. Singulex Cardiac Biomarker Product and Services
Table 66. Singulex Cardiac Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Cardiac Biomarker Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Cardiac Biomarker Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Cardiac Biomarker Sales by Regions (2015-2020) (K Units)
Table 70. Global Cardiac Biomarker Sales Market Share by Regions (2015-2020)
Table 71. Global Cardiac Biomarker Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Cardiac Biomarker Sales by Countries (2015-2020) (K Units)
Table 73. North America Cardiac Biomarker Sales Market Share by Countries (2015-2020)
Table 74. North America Cardiac Biomarker Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Cardiac Biomarker Revenue Market Share by Countries (2015-2020)
Table 76. Europe Cardiac Biomarker Sales by Countries (2015-2020) (K Units)
Table 77. Europe Cardiac Biomarker Sales Market Share by Countries (2015-2020)
Table 78. Europe Cardiac Biomarker Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Cardiac Biomarker Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Cardiac Biomarker Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Cardiac Biomarker Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Cardiac Biomarker Sales by Countries (2015-2020) (K Units)
Table 83. South America Cardiac Biomarker Sales Market Share by Countries (2015-2020)
Table 84. South America Cardiac Biomarker Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Cardiac Biomarker Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Cardiac Biomarker Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Cardiac Biomarker Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Cardiac Biomarker Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Cardiac Biomarker Revenue Market Share by Countries (2015-2020)
Table 90. Global Cardiac Biomarker Sales by Type (2015-2020) (K Units)
Table 91. Global Cardiac Biomarker Sales Share by Type (2015-2020)
Table 92. Global Cardiac Biomarker Revenue by Type (2015-2020) (USD Million)
Table 93. Global Cardiac Biomarker Revenue Share by Type (2015-2020)
Table 94. Global Cardiac Biomarker Sales by Application (2015-2020) (K Units)
Table 95. Global Cardiac Biomarker Sales Share by Application (2015-2020)
Table 96. Global Cardiac Biomarker Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Cardiac Biomarker Market Share Forecast by Regions (2021-2025)
Table 98. Global Cardiac Biomarker Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Cardiac Biomarker Market Share Forecast by Type (2021-2025)
Table 100. Global Cardiac Biomarker Sales Forecast by Application (2021-2025)
Table 101. Global Cardiac Biomarker Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cardiac Biomarker Picture
Figure 2. Global Sales Market Share of Cardiac Biomarker by Type in 2019
Figure 3. Creatine kinase (CK) MB Picture
Figure 4. Troponin (cTnI and cTnT) Picture
Figure 5. BNP & NT-proBNP Picture
Figure 6. Myogloblin Picture
Figure 7. Others (hs-CRP, D-Dimer, etc.) Picture
Figure 8. Cardiac Biomarker Sales Market Share by Application in 2018
Figure 9. Myocardial Infarction Picture
Figure 10. Congestive Heart Failure Picture
Figure 11. Acute Coronary Syndrome Picture
Figure 12. Atherosclerosis Picture
Figure 13. Others Picture
Figure 14. Global Cardiac Biomarker Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Cardiac Biomarker Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Cardiac Biomarker Sales Market Share by Manufacturer in 2019
Figure 35. Global Cardiac Biomarker Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Cardiac Biomarker Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Cardiac Biomarker Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 40. Global Cardiac Biomarker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Cardiac Biomarker Revenue Market Share by Regions (2015-2020)
Figure 42. Global Cardiac Biomarker Revenue Market Share by Regions in 2018
Figure 43. North America Cardiac Biomarker Sales and Growth Rate (2015-2020)
Figure 44. Europe Cardiac Biomarker Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Cardiac Biomarker Sales and Growth Rate (2015-2020)
Figure 46. South America Cardiac Biomarker Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Cardiac Biomarker Sales and Growth Rate (2015-2020)
Figure 48. North America Cardiac Biomarker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Cardiac Biomarker Sales Market Share by Countries (2015-2020)
Figure 50. North America Cardiac Biomarker Sales Market Share by Countries in 2018
Figure 51. North America Cardiac Biomarker Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Cardiac Biomarker Revenue Market Share by Countries in 2018
Figure 53. United States Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Canada Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Mexico Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Europe Cardiac Biomarker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Cardiac Biomarker Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Cardiac Biomarker Revenue Market Share by Countries in 2019
Figure 59. Germany Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 60. UK Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 61. France Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Russia Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Italy Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Asia-Pacific Cardiac Biomarker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Cardiac Biomarker Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Cardiac Biomarker Revenue Market Share by Regions 2019
Figure 67. China Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Japan Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Korea Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 70. India Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Southeast Asia Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 72. South America Cardiac Biomarker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Cardiac Biomarker Sales Market Share by Countries in 2019
Figure 74. South America Cardiac Biomarker Revenue Market Share by Countries in 2019
Figure 75. Brazil Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Argentina Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Middle East and Africa Cardiac Biomarker Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Cardiac Biomarker Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Cardiac Biomarker Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Cardiac Biomarker Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Egypt Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Turkey Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 84. South Africa Cardiac Biomarker Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Global Cardiac Biomarker Sales and Growth Rate (2021-2025) (K Units)
Figure 86. Global Cardiac Biomarker Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Cardiac Biomarker Market Forecast (2021-2025) (K Units)
Figure 88. Europe Sales Cardiac Biomarker Market Forecast (2021-2025) (K Units)
Figure 89. Asia-Pacific Sales Cardiac Biomarker Market Forecast (2021-2025) (K Units)
Figure 90. South America Sales Cardiac Biomarker Market Forecast (2021-2025) (K Units)
Figure 91. Middle East & Africa Sales Cardiac Biomarker Market Forecast (2021-2025) (K Units)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel